Gadsden Properties, Revenue Growth Rates (FCRE), Current and Historic Growth - CSIMarket
CSIMarket
 


Gadsden Properties, Inc.  (FCRE)
 

FCRE's Revenue Growth by Quarter and Year

Gadsden Properties,'s Revenue results by quarter and year




FCRE Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.01
1st Quarter March 0.02
FY 0.03

FCREs Annual Revenue
Gadsden Properties,'s Revenue in the fiscal year 2018 $ 0.04 millions
Gadsden Properties,'s Revenue in the fiscal year 2017 $ 0.00 millions
Gadsden Properties,'s Revenue in the fiscal year 2016 $ 38.40 millions
Gadsden Properties,'s Revenue in the fiscal year 2015 $ 75.89 millions
Gadsden Properties,'s Revenue in the fiscal year 2014 $ 163.54 millions




FCRE Revenue second quarter 2019 Y/Y Growth Comment
Gadsden Properties, Inc. achieved in the second quarter 2019, above Company average Revenue growth of 40% year on year, to $ 0.01 millions.

Looking into second quarter 2019 results within Medical Equipment & Supplies industry 37 other companies have achieved higher Revenue growth. While Gadsden Properties, Inc.' s Revenue rise of 40% ranks overall at the positon no. 717 in the second quarter 2019.




FCRE Revenue ( Y/Y Growth %) 2019
2018 2017 2016
4th Quarter December - - - -11.81 %
3rd Quarter September - - - -59.67 %
2nd Quarter June 40 % - - -43.57 %
1st Quarter March - - -68.48 % -45.67 %
FY   - -98.57 % -90.88 % -

Financial Statements
Gadsden Properties,'s second quarter 2019 Revenue $ 0.01 millions FCRE's Income Statement
Gadsden Properties,'s second quarter 2018 Revenue $ 0.01 millions Quarterly FCRE's Income Statement


FCRE Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
4th Quarter December - 0 % - 19.28 %
3rd Quarter September - 100 % - -35.41 %
2nd Quarter June -30 % - - 0.09 %
1st Quarter March 0 % - -59.12 % 14.36 %
FY (Year on Year)   - -98.57 % -90.88 % -




Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #172
Overall #717

Revenue Y/Y Growth Statistics
High Average Low
28.47 % -35.44 % -100 %
(Dec 31 2015)   (Mar 31 2018)
Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #172
Overall #717
Revenue Y/Y Growth Statistics
High Average Low
28.47 % -35.44 % -100 %
(Dec 31 2015)   (Mar 31 2018)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Gadsden Properties,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
268.3 % -0.54 % -100 %
(Mar 31 2015)  


FCRE's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2019 Gadsden Properties, Inc. disclosed fall in Revenue from the first quarter by -30% to $ 0.01 millions, from $ 0.02 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 163 other companies have achieved higher Revenue quarter on quarter growth. While Gadsden Properties,'s Revenue growth quarter on quarter, overall rank is 4072.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #164
Healthcare Sector #562
Overall #4072
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #164
Healthcare Sector #562
Overall #4072
Revenue Q/Q Growth Statistics
High Average Low
268.3 % -0.54 % -100 %
(Mar 31 2015)  


FCRE's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2019 Gadsden Properties, Inc. disclosed fall in Revenue from the first quarter by -30% to $ 0.01 millions, from $ 0.02 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 163 other companies have achieved higher Revenue quarter on quarter growth. While Gadsden Properties,'s Revenue growth quarter on quarter, overall rank is 4072.


Gadsden Properties,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Revenue 12 Months Ending $ 0.06 $ 0.06 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # 3604 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 5.36 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 1948 # 831 # 0 # 0 # 831


Cumulative Revenue growth Comment
Gadsden Properties, saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 40% year on year, to $ 0 millions if the fiscal year would have ended in Jun 30 2019.
Gadsden Properties,'s trailing twelve months Revenue growth was higher than company's average -38.08% and higher than % growth in Mar 31 2019.
But from twelve months ended Mar 31 2019 rise was beneth at 5.36 % from $0.06 millions achieved in the period from Mar 31 2019 to Jun 30 2018.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -35.3%.

In the Healthcare sector 810 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3604.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 79
Healthcare Sector # 811
Overall # 3604

Revenue TTM Y/Y Growth Statistics
High Average Low
1.82 %
-38.08 %
-75.72 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 79
Sector # 288
S&P 500 # 1948
Cumulative Revenue growth Comment
Gadsden Properties, saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 40% year on year, to $ 0 millions if the fiscal year would have ended in Jun 30 2019.
Gadsden Properties,'s trailing twelve months Revenue growth was higher than company's average -38.08% and higher than % growth in Mar 31 2019.
But from twelve months ended Mar 31 2019 rise was beneth at 5.36 % from $0.06 millions achieved in the period from Mar 31 2019 to Jun 30 2018.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -35.3%.
The momentum is even more impressive from twelve months ended Mar 31 2019 exhibited at 5.36 % increase from $0.06 millions in the period from Mar 31 2019 to Jun 30 2018.

In the Healthcare sector 810 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3604.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 79
Healthcare Sector # 811
Overall # 3604

Revenue TTM Y/Y Growth Statistics
High Average Low
1.82 %
-38.08 %
-75.72 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 79
Sector # 288
S&P 500 # 1948




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FCRE's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2019
Novan Inc 69.65%$ 69.646 millions
Bluebird Bio Inc 69.35%$ 69.354 millions
Nephros Inc 69.03%$ 69.034 millions
Adamas Pharmaceuticals Inc67.76%$ 67.759 millions
Immunogen inc 67.35%$ 67.352 millions
Sorrento Therapeutics Inc 65.53%$ 65.525 millions
Inspire Medical Systems inc 64.86%$ 64.856 millions
Avedro Inc63.45%$ 63.447 millions
Precision Optics Corporation Inc 62.94%$ 62.937 millions
Aveo Pharmaceuticals Inc 62.36%$ 62.356 millions
Therapeuticsmd Inc 61.54%$ 61.543 millions
Aspira Women s Health inc 61.30%$ 61.299 millions
Aclaris Therapeutics Inc 59.55%$ 59.548 millions
Electrocore Inc 58.37%$ 58.368 millions
Clearpoint Neuro Inc 58.32%$ 58.315 millions
Establishment Labs Holdings Inc 58.17%$ 58.173 millions
Bionik Laboratories Corp 57.66%$ 57.655 millions
Quanterix Corporation56.61%$ 56.612 millions
Wave Life Sciences Ltd 56.34%$ 56.344 millions
Fulgent Genetics Inc 56.00%$ 56.000 millions
Elite Pharmaceuticals Inc 54.97%$ 54.968 millions
Otonomy Inc 54.47%$ 54.472 millions
Regenerx Biopharmaceuticals inc 53.47%$ 53.471 millions
Nuwellis Inc 52.59%$ 52.593 millions
Intercept Pharmaceuticals inc 52.15%$ 52.151 millions
Irhythm Holdings Inc 50.36%$ 50.359 millions
Alnylam Pharmaceuticals Inc 49.51%$ 49.510 millions
Organogenesis Holdings Inc 49.13%$ 49.127 millions
Repligen Corp48.11%$ 48.105 millions
Ethema Health Corporation 47.22%$ 47.219 millions


About Gadsden Properties, Revenue Growth Rates (FCRE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.